Patents by Inventor Jeff Shindelman

Jeff Shindelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Device and method for measuring LDL-associated cholesterol
    Patent number: 7824879
    Abstract: An assay device and method for determining the concentration of low density lipoprotein (LDL)-associated cholesterol (LDL-C) in a body-fluid sample, such as a blood sample is described.
    Type: Grant
    Filed: January 9, 2008
    Date of Patent: November 2, 2010
    Assignee: Cholestech Corporation
    Inventors: Shireen Khan, Suyue Qian, Jeff Shindelman, George E. Withers, III, Eileen Gee, William H. Chapman, Jr., Greg Bennett, Thomas D. Schaal
  • Device and method for measuring LDL-associated cholesterol
    Publication number: 20080166745
    Abstract: An assay device and method for determining the concentration of low density lipoprotein (LDL)-associated cholesterol (LDL-C) in a body-fluid sample, such as a blood sample is described.
    Type: Application
    Filed: January 9, 2008
    Publication date: July 10, 2008
    Applicant: Cholestech Corporation
    Inventors: Shireen Khan, Suyue Qian, Jeff Shindelman, George E. Withers, Eileen Gee, William H. Chapman, Greg Bennett, Thomas D. Schaal
  • Determination of high molecular weight analytes using a .beta.-galactosidase complementation assay
    Patent number: 5244785
    Abstract: A method for detecting the presence of a high-molecular-weight analyte, which uses a variation on complementation assays, comprising (1) providing an enzyme donor (ED)complex comprising ED coupled to an analyte-specific binding molecule, wherein the ED complex retains measurable complementation activity such that active .beta.-galactosidase is formed in the presence of an enzyme acceptor (EA); (2) contacting the ED complex and EA in the presence of a sample suspected of containing a high-molecular-weight analyte that reacts specifically with the analyte-specific binding molecule; and (3) relating the presence of the analyte in the sample to the formation of active .beta.-galactosidase enzyme.
    Type: Grant
    Filed: February 1, 1991
    Date of Patent: September 14, 1993
    Assignee: Microgenics Corporation
    Inventors: Rueyming Loor, Jeff Shindelman, Pyare L. Khanna